Lv1
40 积分 2022-07-22 加入
Precision Oncology: 2025 in Review
12天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已完结
Mapping the effectiveness and risks of GLP-1 receptor agonists
1个月前
已完结
The non-small-cell lung cancer drug market
1个月前
已完结
A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2
3个月前
已完结
Discovery of potent and selective CDK2 inhibitors with high safety and favorable bioavailability for the treatment of cancer
5个月前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
5个月前
已完结
First-In-Human Phase 1/2a Study of the First-In-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer
5个月前
已完结
Diagnosis and Treatment of Type 2 Diabetes in Adults
5个月前
已完结
皖公网安备34019202002308
